Multiple Sclerosis: Understanding Infusion Disease-Modifying Therapies
Several of the most effective medications for slowing MS progression are only available as infusions. Here's how they work and what a treatment visit involves.
What is multiple sclerosis?
Multiple sclerosis (MS) is a chronic condition in which the immune system attacks myelin, the protective coating around nerve fibers in the brain, spinal cord, and optic nerves. When myelin is damaged, the signals nerves send to the rest of the body slow down or get disrupted, which is what produces MS symptoms.
Symptoms vary widely depending on which nerves are affected, but commonly include vision changes or eye pain (often an early sign, known as optic neuritis), numbness or tingling in the limbs or face, muscle weakness or stiffness, problems with balance and coordination, fatigue, and bladder control issues. Most people are diagnosed with relapsing-remitting MS, where symptoms flare and then partially or fully improve, though some go on to develop a more steadily progressive form.
Why infusion therapy is part of MS treatment
There's no cure for MS, but disease-modifying therapies (DMTs) can reduce how often relapses happen and slow the accumulation of damage over time. While many DMTs are taken as pills or self-injections, several of the most effective options are administered only by IV infusion, precisely because they work by resetting or depleting specific populations of immune cells, a process that requires controlled, monitored delivery.
Common infusion medications for MS include ocrelizumab (Ocrevus), a B-cell therapy typically given twice a year after two initial starter doses; natalizumab (Tysabri), usually infused monthly to reduce immune cell activity in the central nervous system; and alemtuzumab (Lemtrada), given in short, intensive courses spaced roughly a year apart. Each has a different mechanism, monitoring schedule, and safety profile, which is why the right choice depends on your specific diagnosis and history.
What to expect during an infusion visit
MS infusions are typically longer than many other infusion treatments, often a few hours, and pre-medication such as an antihistamine, acetaminophen, or a steroid is commonly given beforehand to reduce the risk of an infusion reaction. Reactions can occur during the infusion or up to 24 hours afterward, so being monitored by clinical staff who know what to watch for matters, especially for the first couple of treatments.
Because some MS infusion therapies carry specific risks (for example, natalizumab requires ongoing monitoring for a rare but serious brain infection called PML), your care team will review your history and run periodic screening tests as part of your treatment plan, not just on the day of infusion.
Why physician oversight matters
MS treatment isn't one-size-fits-all, and the right infusion therapy for one patient may not be right for another based on disease activity, prior treatments, and other health factors. An infusion suite with a physician on site, not just reachable by phone, means dosing questions, side effects, or changes in symptoms can be addressed in real time, and your neurologist stays looped in on how you're responding.
Considering infusion therapy for MS?
Our physician-led team works directly with your neurologist to coordinate care, handle prior authorization, and make every visit as comfortable as possible.
Call (551) 336-5580See all conditions we treat at Specialty Infusions →
This article is for general educational purposes and is not a substitute for medical advice. Treatment decisions should always be made with your physician based on your individual diagnosis and health history.